Blog
03-12-2025Cross-posted from: NIAID Newsroom The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox…
NIAID
Tecovirimat Is Safe but Ineffective as Treatment for Clade II Mpox - Blog
NIH Study Finds Tecovirimat Was Safe but Did Not Improve Mpox Resolution or Pain 12-16-2024Cross-posted from: NIAID Newsroom The antiviral drug tecovirimat did not reduce the time to lesion resolution or have an effect on pain among adults with mild… - Blog
NIAID Researchers Find Anti-HIV Antibodies Affect Immune Responses When Delivered During Acute Infection 11-21-2024Cross-posted from: National Institute of Allergy and Infectious Diseases National Institute of Allergy and Infectious Diseases (NIAID) scientists examined the… - Blog
Kidney Transplantation Between Donors and Recipients with HIV Is Safe 10-17-2024Cross-posted from: NIAID Newsroom Kidney transplantation from deceased donors with HIV (HIV D+) to recipients with HIV (HIV R+) was safe and comparable to… - Blog
Defining the Goals of HIV Science Through 2034 10-02-2024Cross-posted from: NIAID Now Blog This blog is the third in a series about the future of NIAID's HIV clinical research enterprise. For more information, please… - Blog
SARS-CoV-2 Rapidly Evolves in People with Advanced HIV 09-11-2024Cross-posted from: NIAID Now NIAID Researchers Uncover How SARS-CoV-2 Variants May Emerge in People with Weakened Immune Systems A NIAID study revealed how… - Blog
ICYMI: Research Roundup from AIDS 2024 08-15-2024A brief roundup of key topics of HIV.gov’s coverage of AIDS 2024, including HIV prevention, cure research, and more. - Blog
We Should Leverage the Successes of HIV Care to Prevent Overdose Mortality 08-01-2024Cross-posted from: NIDA blog For complex reasons, HIV and substance use have been inextricably linked since the HIV epidemic began more than four decades ago… - Blog
Exploratory Analysis Associates HIV Drug Abacavir with Elevated Cardiovascular Disease Risk in Large Global Trial 07-26-2024Cross-posted from: NIAID NewsroomCurrent or previous use of the antiretroviral drug (ARV) abacavir was associated with an elevated risk of major adverse… - Blog
An Emergency Department Screening Strategy Identifies Asymptomatic and Undiagnosed Syphilis 06-05-2024As syphilis rates continue to rise in the United States, emergency departments may be a way for people with limited healthcare access to get screening and… - Blog
FYI Video: A Conversation About the Importance of HIV Vaccine Research 06-05-2024Louis Shackelford of the HIV Vaccine Trials Network and NIH’s Carl Dieffenbach discuss why a safe, effective, and durable HIV vaccine is important for… - Blog
NIAID Marks HIV Vaccine Awareness Day 2024 05-17-2024Cross-posted from: NIAID NowVaccines consistently transform public health, and HIV vaccine research has been a pillar of NIAID’s scientific mission since the… - Blog
Help Scientists Find a Safe and Effective Mpox Treatment 05-16-2024The STOMP trial is evaluating the antiviral drug tecovirimat (TPOXX) as a treatment for mpox. Learn how individuals, providers, and community organizations can… - Blog
Resources for 2024 HIV Vaccine Awareness Day 05-14-2024Resources to highlight HIV Vaccine Awareness Day on May 18, a day to recognize the community members, health professionals, and scientists working together to… - Blog
NIH Ending the HIV Epidemic Projects Bridge Gaps Between HIV Research and Public Health Practice (VIDEO) 04-09-2024Cross-posted from: NIAID Now Blog The National Institutes of Health recently issued $26M in awards to HIV research institutions in its fifth year supporting… - Blog
Long-Acting HIV Treatment Benefits Adults with Barriers to Daily Pill Taking and Adolescents with Suppressed HIV 03-06-2024Cross-posted from: NIH Newsroom Long-acting, injectable antiretroviral therapy (ART) suppressed HIV replication better than oral ART in people who had… - Blog
Children Surpass a Year of HIV Remission after Treatment Pause 03-06-2024Cross-posted from: NIH Newsroom Four children have remained free of detectable HIV for more than one year after their antiretroviral therapy (ART) was paused… - Blog
Addressing Liver and Cardiovascular Disease among People with HIV and HIV Prevention During Pregnancy: Dr. Dieffenbach’s Second Update from CROI 2024 03-06-2024On Tuesday at the 2024 Conference on Retroviruses and Opportunistic Infections (CROI), HIV.gov spoke with NIH’s Dr. Carl Dieffenbach about research on common… - Blog
NIAID’s Dr. Jeanne Marrazzo Previews CROI 2024 03-04-2024HIV.gov opened our coverage of the 2024 Conference on Retroviruses and Opportunistic Infections (CROI) today with a conversation with Jeanne Marrazzo, M.D., M… - Blog
Follow HIV.gov Next Week: Key HIV Research Updates from CROI 2024 02-27-2024Next week, HIV.gov will be sharing updates on the latest HIV research from the 2024 Conference on Retroviruses and Opportunistic Infections (CROI), taking…